Insomnia in children: When are hypnotics indicated?

Pediatric Drugs

Volumn 4, Issue 6, 2002, Pages 391-403

  Younus, M ^a,b   Labellarte, M J ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b Villa Maria Behavioral Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALIMEMAZINE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; BEVITAMEL; CLONIDINE; CYANOCOBALAMIN; DIPHENHYDRAMINE; DOXYLAMINE; ESTAZOLAM; FLUMAZENIL; FOLIC ACID; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; MELATONIN; MEPERGAN; METHYLPHENOBARBITAL; MIDAZOLAM; NEUROLEPTIC AGENT; NIAPRAZINE; PENTOBARBITAL; PETHIDINE; PLACEBO; PROMETHAZINE; PROPOFOL; RISPERIDONE; SIMPLY SLEEP; TRIAZOLAM; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM TARTRATE;

ADOLESCENT; ADULT; ANXIETY NEUROSIS; ATTENTION DEFICIT DISORDER; BEHAVIOR MODIFICATION; BEHAVIOR THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HUMAN; INFANT; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBESITY; PARENT COUNSELING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEDATION; SLEEP DISORDER; SUBSTANCE ABUSE; TREATMENT INDICATION;

EID: 0036086996     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200204060-00006     Document Type: Review

References (98)

1. Trouble sleeping and anxiety/depression in childhood
2. Childhood insomnia due to disorderly habits
3. Sleep disorders in healthy children follows often a 'learnt' behavioral pattern: Diurnal rhythm disturbances are dominating among children with functional disabilities
4. Sleep problems of elementary school children: A community survey
5. Pediatric psychopharmacology: Problems and prospects
6. Sleep and psychiatric symptoms in school-age children
7. Sleep disturbance in young children
8. Sleep habits and sleep disturbance in elementary school-aged children
9. Evaluation of insomnia: Validity of three questionnaires
10. The Pittsburgh sleep diary
11. The validity of the Dutch questionnaire (SDQ)
12. The sleep disturbance scale for children (SDSC): Construction and validation of an instrument to evaluate sleep disturbances in childhood and adolescence
13. The children's sleep habits questionnaire (QSHQ): Psychometric properties of a survey instrument for school-aged children
14. Pediatric sleep questionnaire (PSQ): Validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness and behavioral problems
15. The multidimensional anxiety scales for children (MASC): Factor structure, reliability and validity
16. Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): A replication study
17. The children's depression inventory (CDI)
18. Schedule for affective disorders and schizophrenia for school age children: Present and lifetime version (K-SADS-PL): Initial reliability and validity data
19. Fluoxamine for the treatment of anxiety disorders in children and adolescents
20. Children's Yale-Brown obsessive compulsive scale: Reliability and validity
21. Assessing positive and negative symptoms in children and adolescents
22. The Yale global tic severity scale: Initial testing on a clinician-rated scale of tic severity
23. Sleep problems in early childhood: Continuities, predictive factors and behavioral correlates
24. Childhood sleep problems: Association with prenatal factors and maternal distress/depression
25. Sleep breathing and sleep movement disorders masquerading as insomnia in sexual-assault survivors
26. Increased nocturnal activity and impaired sleep maintenance in abused children
27. Sleep disturbance in children with attention-deficit/hyperactivity disorder: A comparative study with healthy siblings
28. Decreased sleep quality and increased sleep related movements in patients with Tourette's syndrome
29. Sleep phobia in middle childhood: Our view of six cases
30. Sleep abnormalities in mentally retarded autistic subjects: Down's syndrome with mental retardation and normal subjects
31. Sleep patterns in children and young adults with mental retardation and severe behavior disorders
32. An investigation on sleep disturbance of autistic children
33. Research units on pediatric psychopharmacology (RUPP) autism network: Background and rationale for an initial controlled study of risperidone
34. Risperidone for insomnias in PDDs
35. Assessment in multisite randomized clinical trials of patients with autistic disorders: The autism RUPP network
36. Usefulness of melatonin for developmental sleep and emotional/behavior disorders: Studies of melatonin trial on 50 patients with developmental disorders
37. Melatonin for treatment of sleep disorders in children with developmental disabilities
38. The treatment of pediatric anxiety disorders
39. Complications of SSRI treatment
40. Unraveling sleep problems in treated and untreated children with ADHD
41. Bupropion versus methylphenidate in the treatment of attention deficit hyperactivity disorder
42. Bupropion hydrochloride in attention deficit disorder with hyperactivity
43. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit hyperactivity disorder
44. Practical assessment and treatment of attention-deficit/hyperactivity disorder
45. Sleep polysomnography as a predictor of recurrence in MDD
46. A double blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
47. Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial
48. Cognitive-behavioral treatment of adolescent depression: Efficacy of acute group treatment and booster sessions
49. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: A multicenter trial
50. Clomipramine treatment of childhood obsessive-compulsive disorder: A double blind controlled study
51. Fluoxamine for children and adolescents with obsessive-compulsive disorder: A randomized controlled multicenter trial
52. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder
53. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
54. Clonidine treatment of Gilles De la Tourette's syndrome
55. The psychiatry of 'Tourette Syndrome'
56. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
57. Effect size of lithium, divalproate sodium and carbamazepine in children and adolescents with bipolar disorder
58. Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison
59. A controlled evaluation of loxitane in 75 adolescent schizophrenic patients
60. Psychosis in children: Diagnosis and treatment
61. Management of obstructive sleep apnea in childhood
62. Restless legs syndrome and periodic limb movement disorder in children and adolescents: Comorbidity with attention-deficit hyperactivity disorder
63. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD
64. Restless leg syndrome and periodic limb movement disorder (PLMD): Acute placebo-controlled sleep laboratory studies with clonazepam
65. Review and update: Benzodiazepines in childhood and adolescence
66. A systematic review of treatment of settling problems and night waking in young children
67. Reducing sleep disruptions in young children, evaluation of therapist-guided and written information approaches: A brief report
68. Night waking in infants: Effects of providing advice and support for parents
69. Reducing nocturnal awakening and crying episodes in infants and young children: A comparison between scheduled awakening and systematic ignoring
70. Reducing bedtime tantrums: Comparison between positive routines and graduated extinction
71. Management of sleep problems in preschool children
72. Behavioral approaches to sleep/wake disorders in children and adolescents
73. Evaluation of flurazepam and placebo on sleep disorders in childhood
74. Niaprazine vs chlordesmethyldiazepam in sleep disturbance in pediatric outpatients
75. Clinical trial with lorazepam in preoperative anxiety
76. Clonazepam in childhood anxiety disorders
77. Reversal of triazolam and zolpidem induced memory impairment by flumazenil
78. Role of flumazenil for paradoxical reaction to midazolam during endoscopic procedures in children
79. Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia
80. Nocturnal profile of growth hormone secretion during sleep induced by zolpidem: A double-blind study in young adults and children
81. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic
82. Zolpidem (Ambien): A pediatric case series
83. Pharmacokinetics, pharmacodynamics and relative pharmacokinetics/pharmacodynamics profiles of zaleplon and zolpidem
84. Clinical evaluation of diphenhydramine hydrochloride for the treatment of insomnia in psychiatric patients: A double-blind study
85. Trazodone is slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders
86. Combining methylphenidate and clonidine: Pharmacologic questions and news reports about sudden death
87. Combining methylphenidate and clonidine: The role of post-marketing surveillance
88. A double-blind drug trial of treatment in young children with waking problems
89. Controlled trial of trimeprazine tartrate for night waking
90. Treatment of infant sleep disturbance by trimeprazine in combination with extinction
91. Eosinophilia-myalgia syndrome in L-tryptophan-exposed patients
92. Circadian rhythm sleep disorders in adolescents: Clinical trials of combined treatments based on chronobiology